Concentra Group Holdings Parent

CON NYSE Health Care Services Financials FY2022–FY2025

Concentra Group Holdings Parent's revenue rose 13.8% to $2.2 billion in fiscal 2025. Its operating margin was 15.4%, down from 16.0% a year earlier. Free cash flow was $197 million, down 6.3%. It paid out $54 million in dividends and buybacks, 28% of free cash flow. The diluted share count rose 12.3%.

Last close · Oct 23, 2026

$39.25

1.8%

Value it Compare

Revenue

$2.2B

13.9% vs prior year

Operating margin

15.4%

0.6 pts

Net income

$166M

0.1%

Free cash flow

$197M

6.3%

Return on capital

14.9%

Market cap

$5.0B

Oct 23 close

P/E

25.3x

On $1.55 EPS (TTM)

What Concentra Group Holdings Parent does

No business description yet.

Legal name: CONCENTRA GROUP HOLDINGS PARENT, INC.
Fiscal year ends: December 31, 2025
Latest annual report: —
Accession · CIK: 0002014596-26-000029
0002014596

Revenue and margins

Concentra Group Holdings Parent had $2.2B of revenue in fiscal 2025, up 13.9% on the year before.

Revenue

FY22

Revenue $1.7B

FY23

Revenue $1.8B

FY24

Revenue $1.9B

FY25

Revenue $2.2B

Revenue

Q1 '25

Revenue $501M

Q2 '25

Revenue $551M

Q3 '25

Revenue $573M

Q4 '25

Revenue $539M

Q1 '26

Revenue $570M

Q2 '26

Revenue $606M

Margins, % of revenue

FY22

Gross —

Operating 15.0%

Net 9.7%

FCF 13.2%

FY23

Gross —

Operating 15.7%

Net 9.8%

FCF 9.2%

FY24

Gross —

Operating 16.0%

Net 8.8%

FCF 11.1%

FY25

Gross —

Operating 15.4%

Net 7.7%

FCF 9.1%

Gross Operating Net FCF

Margins, % of revenue

Q1 '25

Gross —

Operating 16.0%

Net 7.8%

FCF −0.8%

Q2 '25

Gross —

Operating 16.3%

Net 8.1%

FCF 11.5%

Q3 '25

Gross —

Operating 16.5%

Net 8.4%

FCF 6.9%

Q4 '25

Gross —

Operating 12.9%

Net 6.4%

FCF 18.3%

Q1 '26

Gross —

Operating 16.8%

Net 8.9%

FCF 1.7%

Q2 '26

Gross —

Operating 19.0%

Net 10.8%

FCF 19.7%

Gross Operating Net FCF

Net income and earnings per share

From fiscal 2022 to 2025, diluted EPS grew −6.7% a year. Loss periods are shown in red.

Net income

FY22

Net income $167M

FY23

Net income $180M

FY24

Net income $167M

FY25

Net income $166M

Net income

Q1 '25

Net income $38.9M

Q2 '25

Net income $44.6M

Q3 '25

Net income $48.3M

Q4 '25

Net income $34.7M

Q1 '26

Net income $50.5M

Q2 '26

Net income $65.3M

Diluted EPS

FY22

Diluted EPS $1.60

FY23

Diluted EPS $1.73

FY24

Diluted EPS $1.46

FY25

Diluted EPS $1.30

Diluted EPS

Q1 '25

Diluted EPS $0.30

Q2 '25

Diluted EPS $0.35

Q3 '25

Diluted EPS $0.38

Q4 '25

Diluted EPS $0.27

Q1 '26

Diluted EPS $0.39

Q2 '26

Diluted EPS $0.51

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)

FY22

Return on capital —

Return on equity —

Return on assets —

FY23

Return on capital —

Return on equity 16.8%

Return on assets 7.8%

FY24

Return on capital —

Return on equity 23.2%

Return on assets 6.9%

FY25

Return on capital 14.9%

Return on equity 49.8%

Return on assets 6.2%

Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $197M in fiscal 2025, 9.1% of revenue. Cash from operations minus capital spending.

Free cash flow

FY22

Free cash flow $228M

FY23

Free cash flow $169M

FY24

Free cash flow $210M

FY25

Free cash flow $197M

Free cash flow

Q1 '25

Free cash flow −$4.0M

Q2 '25

Free cash flow $63.2M

Q3 '25

Free cash flow $39.4M

Q4 '25

Free cash flow $98.5M

Q1 '26

Free cash flow $9.9M

Q2 '26

Free cash flow $120M

Cash from operations vs capital spending

FY22

Cash from operations $274M

Capital spending $46.0M

FY23

Cash from operations $234M

Capital spending $65.0M

FY24

Cash from operations $275M

Capital spending $64.3M

FY25

Cash from operations $279M

Capital spending $82.3M

Cash from operations Capital spending

Cash from operations vs capital spending

Q1 '25

Cash from operations $11.7M

Capital spending $15.7M

Q2 '25

Cash from operations $88.4M

Capital spending $25.2M

Q3 '25

Cash from operations $60.6M

Capital spending $21.2M

Q4 '25

Cash from operations $119M

Capital spending $20.2M

Q1 '26

Cash from operations $21.0M

Capital spending $11.1M

Q2 '26

Cash from operations $135M

Capital spending $15.7M

Cash from operations Capital spending

Dividends, buybacks and share count

Concentra Group Holdings Parent returned $54.5M to shareholders in fiscal 2025, 28% of free cash flow. The diluted share count rose 12.3%.

Dividends and buybacks

FY22

Dividends $0.0M

Buybacks $0.0M

FY23

Dividends $0.0M

Buybacks $0.0M

FY24

Dividends $8.0M

Buybacks $15.4M

FY25

Dividends $32.1M

Buybacks $22.4M

Dividends Buybacks

Dividends and buybacks

Q1 '25

Dividends $0.0M

Buybacks $0.0M

Q2 '25

Dividends $16.0M

Buybacks $0.0M

Q3 '25

Dividends $8.0M

Buybacks $0.0M

Q4 '25

Dividends $8.0M

Buybacks $0.0M

Q1 '26

Dividends $8.0M

Buybacks $15.0M

Q2 '26

Dividends $8.0M

Buybacks $11.0M

Dividends Buybacks

Diluted shares outstanding (annual)

FY22

Diluted shares 0.10B

FY23

Diluted shares 0.10B

FY24

Diluted shares 0.11B

FY25

Diluted shares 0.13B

Value Concentra Group Holdings Parent yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Starting free cash flow Growth, years 1–5 Growth, years 6–10 Growth after year 10 Discount rate

Adds net cash of −$1.5B and divides by 128.3M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Earnings per share EPS growth a year P/E multiple Years ahead Discount rate

Reference multiples: today 25.3x · peers 25.8x · sector 28.4x.

Balance sheet

Cash, debt and the ratios that show how comfortably Concentra Group Holdings Parent can carry it.

Cash vs debt (incl. leases)

FY22

Cash $37.7M

Debt —

FY23

Cash $31.4M

Debt —

FY24

Cash $183M

Debt $1.5B

FY25

Cash $79.9M

Debt $1.6B

Cash Debt

Fiscal year end	FY22	FY23	FY24	FY25
Cash and short-term investments	$37.7M	$31.4M	$183M	$79.9M
Debt incl. finance leases	—	—	$1.5B	$1.6B
Net debt / EBITDA	—	—	3.5x	3.7x
Debt / equity	—	—	5.4x	4.0x
Interest coverage	304.5x	1,301.5x	6.4x	3.1x
Current ratio	—	1.1x	1.4x	1.1x
Quick ratio	—	1.1x	1.4x	1.1x
Total assets	$2.3B	$2.3B	$2.5B	$2.9B
Total liabilities	—	$1.2B	$2.2B	$2.4B
Shareholders' equity	$979M	$1.2B	$276M	$393M
Net debt (− = net cash)	—	—	$1.3B	$1.5B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$14.6M

1 insider

Of sales under plans

100%

$14.6M

Date	Insider	Trade	Shares	Price	Value	Filing
Aug 3, 2026	Robert A OrtenzioDirector	Sold plan	130,000	$31.84	$4.1M	Form 4
Jul 1, 2026	Robert A OrtenzioDirector	Sold plan	130,000	$30.50	$4.0M	Form 4
Jun 1, 2026	Robert A OrtenzioDirector	Sold plan	130,000	$25.00	$3.3M	Form 4
May 8, 2026	Robert A OrtenzioDirector	Sold plan	130,000	$25.00	$3.3M	Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

Test	FY23	FY24	FY25
Net income is positive	✓	✓	✓
Cash from operations is positive	✓	✓	✓
Return on assets rose	—	✕	✕
Cash from operations exceeds net income	✓	✓	✓
Debt fell relative to assets	—	—	✓
Current ratio rose	—	✓	✕
Share count didn't rise	✕	✕	✕
Gross margin rose	—	—	—
Revenue rose relative to assets	—	✓	✓
F-score	— / 9	— / 9	5 / 8
Accruals ratio	−2.4%	−4.5%	−4.2%
Altman Z''	2.90	1.30	1.23

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

Company	Market cap	Growth	Op. margin	FCF margin	ROIC	P/E	F-score
Concentra Group Holdings Parent CON	$5.0B	13.9%	15.4%	9.1%	14.9%	25.3x	5
Hims & Hers Health HIMS	$6.4B	59.0%	4.5%	2.5%	19.0%	—	4	Compare →
Chemed CHE	$6.8B	4.1%	13.4%	12.9%	27.3%	25.8x	5	Compare →
Amn Healthcare Services AMN	$1.9B	−8.5%	−2.0%	8.6%	−2.8%	17.9x	5	Compare →
Lifestance Health LFST	$5.0B	13.9%	1.7%	7.7%	1.2%	99.5x	7	Compare →

4 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV

Fiscal year	FY22	FY23	FY24	FY25
Income statement
Revenue	$1.7B	$1.8B	$1.9B	$2.2B
Operating income	$259M	$288M	$305M	$334M
Interest expense	$0.8M	$0.2M	$47.7M	$109M
Pretax income	$225M	$243M	$231M	$224M
Income tax	$52.7M	$57.9M	$59.5M	$51.0M
Net income	$167M	$180M	$167M	$166M
Diluted EPS	$1.60	$1.73	$1.46	$1.30
Diluted shares	0.10B	0.10B	0.11B	0.13B
Cash flow
Cash from operations	$274M	$234M	$275M	$279M
Capital expenditure	$46.0M	$65.0M	$64.3M	$82.3M
Free cash flow	$228M	$169M	$210M	$197M
Depreciation and amortization	$73.7M	$73.1M	$67.2M	$75.8M
Stock-based compensation	$2.1M	$0.7M	$2.3M	$10.5M
Acquisitions	$9.7M	$6.0M	$7.0M	$333M
Share buybacks	$0.0M	$0.0M	$15.4M	$22.4M
Dividends paid	$0.0M	$0.0M	$8.0M	$32.1M
Dividends and buybacks	$0.0M	$0.0M	$23.4M	$54.5M
Balance sheet
Cash and short-term investments	$37.7M	$31.4M	$183M	$79.9M
Total debt	—	—	$1.5B	$1.6B
Finance lease liabilities	$0.0M	$3.9M	$3.4M	$1.8M
Current assets	—	$294M	$437M	$383M
Current liabilities	—	$275M	$307M	$337M
Inventory	$0.0M	$0.0M	$0.0M	$0.0M
Property and equipment, net	—	$178M	$198M	$225M
Total assets	$2.3B	$2.3B	$2.5B	$2.9B
Total liabilities	—	$1.2B	$2.2B	$2.4B
Shareholders' equity	$979M	$1.2B	$276M	$393M
Margins
Operating margin	15.0%	15.7%	16.0%	15.4%
EBITDA margin	19.3%	19.6%	19.6%	18.9%
Net margin	9.7%	9.8%	8.8%	7.7%
FCF margin	13.2%	9.2%	11.1%	9.1%
Returns
Return on capital	—	—	—	14.9%
Return on capital employed	—	—	14.3%	14.1%
Return on equity	—	16.8%	23.2%	49.8%
Return on assets	—	7.8%	6.9%	6.2%
Growth
Revenue growth	—	6.6%	3.4%	13.9%
Net income growth	—	7.9%	−7.5%	−0.1%
EPS growth	—	8.1%	−15.6%	−11.0%
FCF growth	—	−25.8%	24.2%	−6.3%
Share count change	—	0.4%	9.6%	12.3%
Financial health
Net debt / EBITDA	—	—	3.5x	3.7x
Debt / equity	—	—	5.4x	4.0x
Interest coverage	304.5x	1,301.5x	6.4x	3.1x
Current ratio	—	1.1x	1.4x	1.1x
Quick ratio	—	1.1x	1.4x	1.1x
Capital allocation
Capex / revenue	2.7%	3.5%	3.4%	3.8%
Stock comp / revenue	0.1%	0.0%	0.1%	0.5%
Payouts / FCF	0.0%	0.0%	11.1%	27.7%
Quality scores
Piotroski F-score	—	—	—	5.0
Altman Z''	—	2.9	1.3	1.2
Accruals ratio	—	−2.4%	−4.5%	−4.2%

Source: SEC EDGAR XBRL filings (CIK 0002014596). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.